Study Name | Indication | Description | Location | Stipend | Apply |
---|---|---|---|---|---|
Abbvie M16-852 | Giant Cell Arteritis | A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis | Vandalia, Ohio | $1900 | Apply |
PA0010 | Psoriatic Arthritis | A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ACTIVE REFERENCE (ADALIMUMAB) STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS | Vandalia, Ohio | $1925 | Apply |
PA0011 | Psoriatic Arthritis | A MULTICENTER, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS | Vandalia, Ohio | $440 | Apply |
Contrast-1 | Rheumatoid Arthritis | A 52-week, Phase 3, Multicenter, Randomized, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate | Vandalia, Ohio | $2900 | Apply |
Contrast-3 | Rheumatoid Arthritis | Efficacy and safety of GSK3196165 versus placebo and sarilumab in participants with moderately to severely active rheumatoid arthritis who have an inadequate response to biological DMARDs and/or Janus Kinase inhibitors. | Vandalia, Ohio | $1350 | Apply |
DYV-702 (Allen) | Gout | A randomized, double-blinded, placebo-controlled study of the efficacy and safety of DYV700 for reducing pain associated with Acute Gout Flares. | Vandalia, Ohio | $565 | Apply |
Dyve-702 (Ordway) | Gout | A randomized, double-blinded, placebo-controlled study of the efficacy and safety of DYV700 for reducing pain associated with Acute Gout Flares. | Springboro, Ohio | $565 | Apply |
SEPRA 9535-4416 | Type 2 Diabetes | Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Clinical Trial | Springboro, Ohio | $90 | Apply |
CAMELOT | COVID-19 | Protocol Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Camostat Mesilate for the Treatment of Confirmed COVID-19 in Outpatients | Springboro, Ohio | $200 | Apply |
ACTIV-2 | COVID-19 | Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID) | Springboro, Ohio | $0 | Apply |
PSA-013 | Psoriatic Arthritis | Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. | Springboro, Ohio | $500 | Apply |
M19-944 | Axial Spondyloarthritis | A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult Subjects with Axial Spondyloarthritis | Springboro, Ohio | $2900 | Apply |